Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,665 | 90,853 | 93,281 | 75,470 | 95,299 |
| Marketable Securities | 196,560 | 170,676 | 168,453 | 186,552 | 170,314 |
| Receivables | 51,903 | 62,509 | 56,632 | 56,232 | 55,029 |
| Inventories | 49,791 | 48,428 | 51,649 | 49,487 | 45,347 |
| TOTAL | $379,302 | $391,996 | $388,489 | $382,825 | $380,501 |
| Non-Current Assets | |||||
| PPE Net | 20,469 | 18,009 | 18,046 | 18,352 | 17,834 |
| Intangibles | 32,393 | 33,518 | 34,374 | 35,308 | 36,109 |
| Other Non-Current Assets | 16,949 | 18,019 | 54,010 | 56,835 | 48,152 |
| TOTAL | $69,811 | $69,546 | $106,430 | $110,495 | $102,095 |
| Total Assets | $449,113 | $461,542 | $494,919 | $493,320 | $482,596 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,741 | 6,410 | 7,632 | 6,853 | 6,247 |
| Accrued Expenses | 19,781 | 23,417 | 20,233 | 21,604 | 19,197 |
| Other current liabilities | 24,381 | 19,473 | 18,603 | 16,685 | 14,541 |
| TOTAL | $80,935 | $77,804 | $75,207 | $73,270 | $67,691 |
| Non-Current Liabilities | |||||
| Long Term Debt | 386 | 525 | 655 | 791 | 918 |
| Deferred Revenues | 30,032 | 28,504 | 28,739 | 28,128 | 27,706 |
| Other Non-Current Liabilities | 22,476 | 23,135 | 24,171 | 25,077 | 18,647 |
| TOTAL | $40,534 | $41,999 | $41,141 | $42,493 | $35,282 |
| Total Liabilities | $121,469 | $119,803 | $116,348 | $115,763 | $102,973 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 129,143 | 128,550 | 127,865 | 127,224 | 126,659 |
| Common Shares | 129 | 129 | 128 | 127 | 128 |
| Retained earnings | -120,604 | -101,738 | -57,662 | -52,184 | -46,601 |
| Other shareholders' equity | 2,369 | 2,241 | 821 | -38 | -609 |
| TOTAL | $327,644 | $341,739 | $378,571 | $377,557 | $379,623 |
| Total Liabilities And Equity | $449,113 | $461,542 | $494,919 | $493,320 | $482,596 |